DIS&L is an agency created for the international development of Scrambler Therapy® Technology MC-5A, a medical device for the treatment of chronic neuropathic and oncologic pain resistant to opiates and other types of treatment, including implanted devices. Scrambler Therapy® Technology MC-5A is a medical device based on Scrambler Therapy scientific research and OEM technology. For further information visit: Scrambler Therapy official scientific and clinical information site.
DIS&L selects medical device distributors in all international area.
DIS&L through its law firm is authorized to sign international exclusive agreements, provide maintenance and distributor support for method usage training and other logistics needs. To request a national exclusive agreement the candidate distributor must have minimum requirements listed on the “Distributor Requirement” page.